On June 12-15, 2016, Keystone Symposia organises joint meetings on Common Mechanisms of Neurodegenerative Diseases and Microglia in the Brain in Keystone, Colorado, USA
June 12—16, 2016
Keystone Resort, Keystone, Colorado, USA
Sponsored by BioLegend, Inc., Curemark LLC, FORUM Pharmaceuticals Inc., Merck & Co., Inc., Sangamo BioSciences, Inc. and Takeda Pharmaceutical Company Limited
WARNING: Please be advised that a few meeting participants have received calls and emails from a number of different housing services – “Exhibitors Housing Services”, “Global Housing”, etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies’ representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
Scholarship Deadline: Feb 11, 2016
Discounted Abstract Deadline: Feb 11, 2016
Abstract Deadline: Mar 10, 2016
Discounted Registration Deadline: Apr 12, 2016